Itafos (TSXV:IFOS) - Stock Price, News & Analysis

IFOS Stock Overview

Itafos Inc. operates as a phosphate and specialty fertilizer company.

IFOS fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	0/6
Past Performance	1/6
Financial Health	5/6
Dividends	0/6

Rewards

Trading at 79.7% below our estimate of its fair value

Risk Analysis

Large one-off items impacting financial results

Profit margins (0.8%) are lower than last year (19.4%)

Itafos Inc. Competitors

Western Resources

TSX:WRX

CA$51.0m

5N Plus

TSX:VNP

CA$416.4m

Foraco International

TSX:FAR

CA$311.1m

Dynacor Group

TSX:DNG

CA$184.8m

Price History & Performance

Summary of all time highs, changes and price drops for Itafos
Historical stock prices
Current Share Price	CA$1.30
52 Week High	CA$1.93
52 Week Low	CA$1.08
Beta	-0.98
1 Month Change	1.56%
3 Month Change	-3.70%
1 Year Change	-31.22%
3 Year Change	85.71%
5 Year Change	80.56%
Change since IPO	-58.73%

Itafos' (CVE:IFOS) Soft Earnings Are Actually Better Than They Appear

Mar 29

Recent updates

This Analyst Just Made A Massive Upgrade To Their Itafos (CVE:IFOS) Earnings Forecasts

Feb 18

Can You Imagine How Elated Itafos' (CVE:IFOS) Shareholders Feel About Its 743% Share Price Gain?

Dec 17

Shareholder Returns

	IFOS	CA Chemicals	CA Market
7D	-7.1%	-1.3%	0.7%
1Y	-31.2%	-20.8%	4.9%

Return vs Industry: IFOS underperformed the Canadian Chemicals industry which returned -20.5% over the past year.

Return vs Market: IFOS underperformed the Canadian Market which returned 5.5% over the past year.

Price Volatility

Is IFOS's price volatile compared to industry and market?
IFOS volatility
IFOS Average Weekly Movement	8.4%
Chemicals Industry Average Movement	9.2%
Market Average Movement	9.0%
10% most volatile stocks in CA Market	18.1%
10% least volatile stocks in CA Market	3.0%

Stable Share Price: IFOS has not had significant price volatility in the past 3 months.

Volatility Over Time: IFOS's weekly volatility (8%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
n/a	417	George Delaney	www.itafos.com

Itafos Inc. operates as a phosphate and specialty fertilizer company. It operates through Conda, Arrais, and Development and Exploration segments. The company produces and sells monoammonium phosphate (MAP), MAP with micronutrients, superphosphoric acid, merchant grade phosphoric acid, ammonium polyphosphate, hydrofluorosilicic acid, direct application phosphate rock, single superphosphate (SSP), SSP with micronutrients, and sulfuric acid.

Itafos Inc. Fundamentals Summary

How do Itafos's earnings and revenue compare to its market cap?
IFOS fundamental statistics
Market cap	CA$248.64m
Earnings (TTM)	CA$5.28m
Revenue (TTM)	CA$636.04m

47.1x

P/E Ratio

0.4x

P/S Ratio

Is IFOS overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
IFOS income statement (TTM)
Revenue	US$465.53m
Cost of Revenue	US$346.96m
Gross Profit	US$118.56m
Other Expenses	US$114.70m
Earnings	US$3.86m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)	0.02
Gross Margin	25.47%
Net Profit Margin	0.83%
Debt/Equity Ratio	35.0%

How did IFOS perform over the long term?

See historical performance and comparison

IFOS Stock Overview

Rewards

Risk Analysis

Itafos Inc. Competitors

TSX:WRX

CA$51.0m

TSX:VNP

CA$416.4m

TSX:FAR

CA$311.1m

TSX:DNG

CA$184.8m

Price History & Performance

Recent News & Updates

Itafos Inc., Annual General Meeting, Jun 19, 2024

Itafos' (CVE:IFOS) Soft Earnings Are Actually Better Than They Appear

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

CEO & Director exercised options to buy CA$84k worth of stock.

Third quarter 2023 earnings released: EPS: US$0.016 (vs US$0.043 in 3Q 2022)

Itafos Inc. Narrows its Earnings Guidance for 2023

Recent updates

Itafos Inc., Annual General Meeting, Jun 19, 2024

Itafos' (CVE:IFOS) Soft Earnings Are Actually Better Than They Appear

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

CEO & Director exercised options to buy CA$84k worth of stock.

Third quarter 2023 earnings released: EPS: US$0.016 (vs US$0.043 in 3Q 2022)

Itafos Inc. Narrows its Earnings Guidance for 2023

Little Excitement Around Itafos Inc.'s (CVE:IFOS) Earnings

Now 22% undervalued after recent price drop

Now 20% undervalued after recent price drop

Investor sentiment improves as stock rises 16%

Itafos (CVE:IFOS) Knows How To Allocate Capital Effectively

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Itafos Inc. Provides Earnings Guidance for the Year 2023

Does Itafos (CVE:IFOS) Have A Healthy Balance Sheet?

Itafos Files Updated Feasibility Study for the Farim Phosphate Project

Itafos Inc. Completes Updated Feasibility Study for the Farim Phosphate Project

Consensus EPS estimates increase by 16%

Itafos Inc., Annual General Meeting, Jul 13, 2023

First quarter 2023 earnings released: EPS: US$0.15 (vs US$0.18 in 1Q 2022)

Itafos Announces Notice to Proceed for Husky 1/North Dry Ridge

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Investor sentiment improves as stock rises 22%

Is Itafos (CVE:IFOS) Using Too Much Debt?

Investor sentiment improves as stock rises 16%

Consensus EPS estimates fall by 26%

Price target decreased to CA$5.25

Itafos Inc. Provides Earnings Guidance for Fiscal Year 2022

Price target decreased to CA$5.25

Investor sentiment deteriorated over the past week

Is Itafos (CVE:IFOS) Using Too Much Debt?

Investor sentiment improved over the past week

Consensus EPS estimates increase by 17%

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

Itafos Inc. Appoints Matthew O’Neill as Chief Financial Officer Succeeding George Burdette

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Itafos Inc. Announces Production and Sales of Hydrofluorosilicic Acid at Conda

Investor sentiment improved over the past week

Itafos Inc. Provides Earnings Guidance for the First Half and Second Half of 2022

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

These 4 Measures Indicate That Itafos (CVE:IFOS) Is Using Debt Extensively

Less than half of directors are independent

Itafos Inc., Annual General Meeting, Jun 24, 2022

Itafos Inc. Announces Board Changes

Itafos Inc. Announces Resumption of Sulfuric Acid Production at Arraias

Investor sentiment deteriorated over the past week

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Second quarter 2021 earnings released: EPS US$0.05 (vs US$0.11 loss in 2Q 2020)

Health Check: How Prudently Does Itafos (CVE:IFOS) Use Debt?

First quarter 2021 earnings released: EPS US$0.01 (vs US$0.10 loss in 1Q 2020)

Is Itafos (CVE:IFOS) Using Debt In A Risky Way?

Full year 2020 earnings released: US$0.34 loss per share (vs US$1.02 loss in FY 2019)

This Analyst Just Made A Massive Upgrade To Their Itafos (CVE:IFOS) Earnings Forecasts

Itafos Appoints David Brush as Chief Strategy Officer

Itafos(TSXV:IFOS) dropped from S&P/TSX Venture Composite Index